BioPace helps pharmaceutical companies and CROs reduce costly amendments and accelerate time-to-market with AI-powered protocol intelligence.
Protocol Intelligence
73/100
17
Clinical trial protocols are becoming increasingly complex, causing significant delays and costs.
Increasing complexity is creating bottlenecks in clinical trials
Protocols requiring amendments
Average cost per amendment
Months of delay per amendment
Of lives potentially affected
Overly restrictive or ambiguous eligibility criteria lead to recruitment challenges and increased screen failures.
Over 70% of protocols undergo at least one substantial amendment, each costing an average of £350,000.
Protocol complexity delays trials by up to three months, directly impacting patient access to potentially life-saving therapies.
BioPace serves as an intelligent co-pilot for protocol development, helping you create clearer, more operationally feasible protocols before trials begin.
Our advanced NLP and ML algorithms analyze draft protocols to identify high-complexity areas and quantify operational burden.
Flag potential risks to recruitment or compliance with data-driven insights that help you prevent issues before they arise.
Receive interactive, explainable reports with data-driven suggestions for improvement while maintaining regulatory compliance.
Our SaaS platform uses advanced NLP and Machine Learning to analyze your protocols before trials begin, helping you:
Complex Manual Process
Protocol design relies on manual checks and subjective reviews
Costly Amendments
70% of protocols require amendments costing £350,000 each
Trial Delays
Up to 3 months delay per amendment, affecting patient access
AI-Powered Intelligence
Automated analysis of complexity, operational burden & risk factors
Proactive Improvement
Data-driven recommendations before issues impact your trial
Faster Time to Market
Fewer amendments and delays, resulting in quicker treatment availability
Our platform makes it easy to identify and resolve protocol issues before they impact your trial.
Simply upload your draft protocol document to our secure platform.
Our algorithms analyze the protocol for complexity, inconsistencies, and operational challenges.
Receive a detailed, interactive report highlighting specific issues and opportunities for improvement.
Make informed revisions to your protocol based on our suggestions, and re-analyze as needed.
12 issues detected
Medium-High
82%
-34% estimated
Simplify inclusion criteria #3 and #7 to broaden eligible population
Reduce frequency of non-essential measurements in visit schedule
Clarify ambiguous language in study procedures section 4.2
BioPace helps bring life-saving treatments to patients faster by reducing inefficiencies in clinical trials.
Significant reduction in costly protocol amendments post implementation.
Improved patient enrollment through optimized eligibility criteria.
Average reduction in time-to-market for new therapies.
Average savings per avoided substantial amendment.
We're committed to helping pharmaceutical companies and CROs bring life-saving therapies to patients faster.
Even modest time savings can have significant health impacts. Accelerating the availability of a cancer therapy by three months could translate to thousands of lives extended or improved.
Protocol complexity has become a silent crisis in global healthcare. Our goal is to address this bottleneck in the development of life-saving treatments through intelligent protocol optimization.
Simplified protocols enhance the trial experience for both participants and healthcare professionals. By flagging overly restrictive eligibility criteria, we help make clinical trials more accessible and diverse.
Join us in our mission to accelerate medical innovation through smarter protocol design.